Search Results
Apr 23, 2026, 09:24 ET AdvisorShares Issues Statement on Finalization of Federal Cannabis Rescheduling
MSOS portfolio manager calls action an inflection point for the U.S. cannabis industryBETHESDA, Md., April 23, 2026 /PRNewswire/ --
More news about: AdvisorShares
Apr 23, 2026, 09:08 ET NCCN Announces Awards for Improvement Initiatives for Chronic Myeloid Leukemia (CML)
MapEdgar Jaimes, MD, Memorial Sloan Kettering Cancer CenterAGORA-CML: AI-Guided Optimization of Response and Adverse Event Surveillance in Chronic Myeloid LeukemiaNikolai Podoltsev, MD, PhD, Yale Cancer Center/Smilow Cancer
More news about: National Comprehensive Cancer Network
Apr 23, 2026, 09:02 ET HOPPR Expands Medical Imaging AI Portfolio with Chest Radiography Narrative Model
"The industry is in an arms race where a state-of-the-art model or point solution is outdated in weeks," said Khan Siddiqui, MD, co-founder and CEO of HOPPR. "What matters is flexible, underlying infrastructure that teams can adapt to their specific environment. This model is built
More news about: HOPPR
Apr 23, 2026, 09:00 ET Biotia Publishes Clinical Validation of Advanced UTI Test in Leading Microbiology Journal
clinicians to move beyond the constraints of culture-based testing toward a more comprehensive understanding of infection," said Dorottya Nagy-Szakal, MD, PhD, Chief Medical Officer of Biotia.The BIOTIA-ID Urine Test is already available for clinicians and patients. For more information, visit
More news about: Biotia, Inc.
Apr 23, 2026, 09:00 ET Theradaptive Announces Final Patient Enrolled in RESTORE Feasibility Study Evaluating OsteoAdapt® DE in Dental Procedures
bone regeneration for dental reconstruction using Theradaptive's targeted therapeutic platformFREDERICK, Md., April 23, 2026 /PRNewswire/ --
More news about: Theradaptive
Apr 23, 2026, 09:00 ET New DEWALT Study Identifies Emerging Gap Between AI Training in Trade Schools and Industry Needs
the need for AI training enabling skilled workers to focus on what they do best – buildingTOWSON, Md., April 23, 2026 /PRNewswire/ -- As artificial intelligence (AI) rapidly transforms industries and becomes an
More news about: DEWALT
Apr 23, 2026, 08:32 ET Ziptek Accelerates Global Adoption of ZipE® Biolock™ Tissue Repair Technology; Announces Expansion of Scientific Advisory Board
Director of Orthopedic Trauma for Brandon Regional Hospital, Dr. Anjan Shah MD, sits on Ziptek's Scientific Advisory Board along with several other Chiefs of Departments across the county including Dr. Pete Mangone MD Chief Foot and Ankle with University of Pittsburgh see his review here.
More news about: Ziptek, LLC
Apr 23, 2026, 08:16 ET Speed, Expertise and Advanced Technology Combine to Save an Infant's Heart
Chad Connor, MD, the pediatric electrophysiologist who ultimately implanted the device.But figuring out ways to make big devices fit in little spaces has been
More news about: Cincinnati Children's Hospital Medical Center
Apr 23, 2026, 08:00 ET FERROSA THERAPEUTICS ANNOUNCES SEED FINANCING TO ADVANCE A FIRST-IN-CLASS BISPECIFIC ANTIBODY PROGRAM FOR ANEMIA OF INFLAMMATION
bispecific engineering, and in vivo proof-of-concept studies in disease-relevant animal models.The company appointed co-founder Martin Stern, MD as the Chief Executive Officer. Martin Stern is a physician-scientist and board-certified hematologist with more than 25 years of combined academic and
More news about: Ferrosa Therapeutics AG
Apr 23, 2026, 08:00 ET FERROSA THERAPEUTICS ANNOUNCES SEED FINANCING TO ADVANCE A FIRST-IN-CLASS BISPECIFIC ANTIBODY PROGRAM FOR ANEMIA OF INFLAMMATION
bispecific engineering, and in vivo proof-of-concept studies in disease-relevant animal models.The company appointed co-founder Martin Stern, MD as the Chief Executive Officer. Martin Stern is a physician-scientist and board-certified hematologist with more than 25 years of combined academic and
More news about: Ferrosa Therapeutics AG
Apr 23, 2026, 08:00 ET Repertoire Immune Medicines Announces First Participant Dosed in Phase 1/2 Trial of RPTR-1-201, a T Cell-Targeted Immune Medicine for Advanced Solid Tumors
deep and durable responses in some cancers, yet many patients with advanced solid tumors still have limited treatment options," said Robert Andtbacka, MD, CM, Chief Medical Officer of Repertoire. "RPTR-1-201 is designed to direct a patient's own T cells toward a shared, tumor-selective target. Dosing the
More news about: Repertoire Immune Medicines
Apr 23, 2026, 08:00 ET Gone in 7 days: One-third of homes sell within a week in the fastest markets, while others sit
17.8 %Baltimore, MD8
More news about: Zillow
Apr 23, 2026, 07:11 ET High Levels of Gut Bacterial Wall Toxin Shown to Trigger Lupus Nephritis
blooms in the gut could identify those people at increased risk of lupus nephritis," said study senior investigator and immunologist Gregg Silverman, MD. Dr. Silverman is the Mamdouha S. Bobst Professor of Internal Medicine at the NYU Grossman School of Medicine."Our research reshapes our fundamental
More news about: NYU Langone Health System
Apr 23, 2026, 07:00 ET Nanoscope Therapeutics Announces Participation at Eyecelerator® and ARVO 2026 Annual Meetings
present additional evidence of meaningful clinical benefit in RP patients treated with our multi‑characteristic opsin (MCO) therapy," said Samuel Barone, MD, Chief Medical Officer of Nanoscope. "Sustained, multi-year vision improvement from a one-time treatment has the potential to be truly transformative
More news about: Nanoscope Therapeutics
Apr 23, 2026, 07:00 ET TrendAI™'s AI Security Brief podcast joins the N2K CyberWire network.
FULTON, Md., April 23, 2026 /PRNewswire/ -- N2K
More news about: N2K Networks
Apr 23, 2026, 06:30 ET Lockheed Martin Reports First Quarter 2026 Financial Results
million and free cash flow of $(291) millionReaffirms 2026 financial outlookBETHESDA, Md., April 23, 2026 /PRNewswire/ -- Lockheed Martin Corporation [NYSE: LMT] today reported first quarter 2026 sales
More news about: Lockheed Martin
Apr 22, 2026, 18:26 ET RhythMedix Launches Next-Generation RhythmStar® SL Cardiac Monitor
patient-friendly design with advanced technology and expert oversight, helping clinicians make more confident, timely decisions," stated George Shaw, MD, Electrophysiologist at AHN Allegheny Health Network. "It's a meaningful step forward in how we deliver and manage cardiac care."With
More news about: RHYTHMEDIX
Apr 22, 2026, 17:02 ET Yale Fertility Center Named to Newsweek's List of America's Best Fertility Clinics 2026
testament to our team's dedication to advancing scientific discovery, delivering clinical excellence, and fostering a culture of safety," said Emre Seli, MD, chief of Reproductive Endocrinology and Infertility at Yale School of Medicine and medical director of Yale Fertility Center. "We are proud to celebrate
More news about: Yale School of Medicine
Apr 22, 2026, 16:00 ET ZIEGLER ADVISES CANCER CENTER ONCOLOGY MEDICAL GROUP ON ITS PARTNERSHIP WITH CANCER CARE SPECIALISTS & LEVITATE RIDGE CAPITAL
nationwide."We are excited to partner with Cancer Care Specialists and Levitate Ridge Capital as we begin this next chapter of growth," said Reema Batra, MD of Cancer Center Oncology Medical Group. "Ziegler was an invaluable advisor throughout a comprehensive strategic alternatives process, helping us thoughtfully
More news about: Ziegler
Apr 22, 2026, 15:02 ET NexGen Health Introduces XERF, an Advanced Non-Invasive Solution for Skin Lifting and Rejuvenation in Silicon Valley
firmness, elasticity, and overall skin quality."XERF represents an exciting advancement in non-invasive aesthetic technology," said James Petros, MD, Founder of NexGen Health. "It allows us to address deeper layers of the skin in a way that aligns with our philosophy of delivering effective, medically
More news about: NexGen Health
Apr 22, 2026, 11:31 ET New HFSA Scientific Statement Provides Practical Guidance for Managing Heart Failure with Mildly Reduced Ejection Fraction
often been treated as a gray zone, but patients in this group face real risks, including hospitalization and disease progression," said Jane E. Wilcox MD, MSc, co-lead author of the statement, Bluhm Cardiovascular Institute of Northwestern University, Northwestern Feinberg School of Medicine. "This statement
More news about: Heart Failure Society of America
Apr 22, 2026, 11:07 ET Brain Support Cells Form Previously Unknown Network
Selles, PhD; Michael Cammer, MFA, MAT; Holly Gildea, PhD; Joseph Sall; and Katelyn Chiurri. Other study co-investigators are Chase Redd, Philip Cheung, MD, and Damian Wheeler, PhD, at Translucence Biosystems in Irvine, California; and Aiman Saab, PhD, at the University of Zurich in Switzerland.About
More news about: NYU Grossman School of Medicine and NYU Langone Health
Apr 22, 2026, 10:59 ET Nelson Oyesiku, M.D., Named Chief of Neurosciences at Piedmont
download multimedia:https://www.prnewswire.com/news-releases/nelson-oyesiku-md-named-chief-of-neurosciences-at-piedmont-302750483.htmlSOURCE
More news about: Piedmont Healthcare
Apr 22, 2026, 10:15 ET CyberSecure IPS™ Launches OptiGuard.com to Showcase Next-Generation Fiber Intrusion Detection Platform
BETHESDA, Md., April 22, 2026 /PRNewswire/ -- CyberSecure IPS™ today announced the launch of OptiGuard.com, a dedicated website for Opti-Guard™, its next-generation physical intrusion
More news about: CyberSecure IPS
Apr 22, 2026, 10:06 ET Texas Biomed establishes new Tuberculosis Innovation and Technology Fund to improve research and treatments for world's deadliest infectious disease
mechanisms at a magnitude not previously available in the region."This is a powerful investment in the future of TB research," said Larry Schlesinger, MD, President and CEO of Texas Biomed, and an internationally recognized TB researcher. "The fund allows us to strengthen our scientific capabilities and
More news about: Texas Biomedical Research Institute